ArticleCancer medicine2021

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.

Thomas Chevalier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.